TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Clinical trial NCT04713982 updates: 1. completion date: 2026-10-01 → 2027-10-01 2. primary completion date: 2026-06-30 → 2027-06-30
Clinical trial NCT04713982 updates: 1. completion date: 2026-10-01 → 2027-10-01 2. primary completion date: 2026-06-30 → 2027-06-30
📉 **NEGATIVE** • Medium confidence analysis (67%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical